Founded in 2020, ZeroHarm Sciences operates in Ecommerce offering preventive health wellness solutions focused on long-term physiological stability and regulatory balance. The company develops advance...
Funding stage:
Undisclosed
Last funding:
24/02/2026
Total funding:
$7.20 Mn+
Revenue:
Investors
Employee count:
61
Last 90d
61
Last 90d
Web traffic:
168.34K
168.34K
Last 30d
Last 30d
ZeroHarm Sciences: Cap Table Highlights
A snapshot of cap table and shareholder metrics
Total Shareholders27
Latest Filing Date12 April 2026- Funding Events17
Event-Based View
Event-Based detailed View by Filings
FAQs on Cap Table of ZeroHarm Sciences
As of 13 April 2026, ZeroHarm Sciences's equity is held by 25 shareholders, with the top three being Sachin Darbarwar, Kotak Life Sciences Fund I, and Alkemi Venture Fund II.
Sachin Darbarwar holds the largest stake in ZeroHarm Sciences at 26.1% as of 13 April 2026.
As of 13 April 2026, founders collectively hold 26.1% equity in ZeroHarm Sciences.
As of 13 April 2026, investors collectively hold 35.7% equity in ZeroHarm Sciences.
ZeroHarm Sciences's ESOP pool stands at 5.0% of total equity as of 13 April 2026.
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links